Gene · 3190
Papers3,914
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,914
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of Concern: ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage. | Cell Cycle | 2024 | 40150821 | PubTator, text mining | PubMed |
| Heterogeneous Ribonucleoprotein K Is a Host Regulatory Factor of Chikungunya Virus Replication in Astrocytes. | Viruses | 2024 | 39772225 | PubTator, text mining | PubMed |
| LINC01764 promotes colorectal cancer cells proliferation, metastasis, and 5-fluorouracil resistance by regulating glucose and glutamine metabolism via promoting c-MYC translation. | MedComm (2020) | 2024 | 39534558 | PubTator, text mining | PubMed |
| Insights into the Mode and Mechanism of Interactions Between RNA and RNA-Binding Proteins. | Int J Mol Sci | 2024 | 39518890 | PubTator, text mining | PubMed |
| SUMOylation modification of HNRNPK at the K422 site promotes invasion in glioblastoma. | Int J Biol Sci | 2024 | 39494331 | PubTator, text mining | PubMed |
| Iroquois homeobox 4 (IRX4) derived micropeptide promotes prostate cancer progression and chemoresistance through Wnt signalling dysregulation. | Commun Med (Lond) | 2024 | 39487222 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma. | Open Life Sci | 2024 | 39479349 | PubTator, text mining | PubMed |
| A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry. | Viruses | 2024 | 39459960 | PubTator, text mining | PubMed |
| The MTR4/hnRNPK complex surveils aberrant polyadenylated RNAs with multiple exons. | Nat Commun | 2024 | 39419981 | PubTator, text mining | PubMed |
| The methyltransferase SETD3 regulates mRNA alternative splicing through interacting with hnRNPK. | Cell Insight | 2024 | 39391005 | PubTator, text mining | PubMed |
| Retraction notice to: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage. | Cell | 2024 | 39389056 | Swiss-Prot, curated | PubMed |
| Pan-cancer analysis of ADAR1 with its prognostic relevance in low-grade glioma. | Immunobiology | 2024 | 39340957 | PubTator, text mining | PubMed |
| Comparison of arterial stiffness index predictors in perimenopausal and postmenopausal women. | Women Health | 2024 | 39302289 | PubTator, text mining | PubMed |
| Identification of a lactylation-related gene signature to characterize subtypes of hepatocellular carcinoma using bulk sequencing data. | J Gastrointest Oncol | 2024 | 39279958 | PubTator, text mining | PubMed |
| Interdependent regulation of alternative splicing by SR and hnRNP proteins. | bioRxiv | 2024 | 39229091 | PubTator, text mining | PubMed |
| Computational identification of novel potential genetic pathogenesis and otherwise biomarkers in acute liver allograft rejection. | Heliyon | 2024 | 39170115 | PubTator, text mining | PubMed |
| Correction to "ELF3-AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood". | Cancer Sci | 2024 | 39158539 | PubTator, text mining | PubMed |
| SHP2 mutations promote glycolysis and inhibit apoptosis via PKM2/hnRNPK signaling in colorectal cancer. | iScience | 2024 | 39104405 | PubTator, text mining | PubMed |
| Nuclear RNA: a transcription-dependent regulator of chromatin structure. | Biochem Soc Trans | 2024 | 39082979 | PubTator, text mining | PubMed |
| The contribution of cumulative blood pressure load to dementia, cognitive function and mortality in older adults. | J Hypertens | 2024 | 38989713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3190/papers?page=8